◆英語タイトル:Bio-Rad Laboratories Inc (BIO) - Financial and Strategic SWOT Analysis Review
◆商品コード:SWOT20MY1600
◆発行会社(調査会社):
GlobalData
◆発行日:2020年4月
◆ページ数:55
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Medical Devices
◆販売価格オプション(消費税別)
※
販売価格オプションの説明はこちらで、
ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※
GlobalData社の概要はこちらでご確認いただけます。
【レポートの概要】
Bio-Rad Laboratories Inc (BIO) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights
Bio-Rad Laboratories Inc (Bio-Rad) develops, manufactures and markets a range of products and systems for the life science research, healthcare, analytical chemistry and other markets. The company’s major products include reagents, apparatus, laboratory instruments, test systems, informatics systems, test kits and specialized quality controls. Bio-Rad offers its products to universities and medical schools, industrial research organizations, pharmaceutical manufacturers, government agencies, biotechnology researchers, food producers, food testing laboratories, reference laboratories, hospital and transfusion laboratories, and physician office laboratories. It markets products through direct sales force and also through a network of distributors, agents, brokers and resellers across the world. The company operates in the US, Canada, Latin America, Europe and Asia, among others. Bio-Rad is headquartered in Hercules, California, the US.
Bio-Rad Laboratories Inc Key Recent Developments
Mar 02,2020 BIO-RAD LABORATORIES: Departure of directors or certain officers; election of directors; appointment of certain officers; compensatory arrangements of certain officers.
Feb 13,2020 Bio-Rad reports fourth-quarter and full-year 2019 financial results
Feb 04,2020 Bio-Rad brings FCS express flow cytometry analysis software to ZE5 cell analyzer users
Jan 06,2020 Bio-Rad appoints Dara Grantham Wright Executive Vice President and Clinical Diagnostics Group President
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Bio-Rad Laboratories Inc – Key Facts
Bio-Rad Laboratories Inc – Key Employees
Bio-Rad Laboratories Inc – Key Employee Biographies
Bio-Rad Laboratories Inc – Major Products and Services
Bio-Rad Laboratories Inc – History
Bio-Rad Laboratories Inc – Company Statement
Bio-Rad Laboratories Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Bio-Rad Laboratories Inc – Business Description
Business Segment: Clinical Diagnostics
Overview
Performance
Key Stats
Business Segment: Life Science
Overview
Performance
Key Stats
Geographical Segment: Asia
Performance
Geographical Segment: Europe
Performance
Geographical Segment: Other
Target Markets
Performance
Geographical Segment: United States
Performance
R&D Overview
Bio-Rad Laboratories Inc – Corporate Strategy
Bio-Rad Laboratories Inc – SWOT Analysis
SWOT Analysis – Overview
Bio-Rad Laboratories Inc – Strengths
Bio-Rad Laboratories Inc – Weaknesses
Bio-Rad Laboratories Inc – Opportunities
Bio-Rad Laboratories Inc – Threats
Bio-Rad Laboratories Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Bio-Rad Laboratories Inc, Medical Equipment, Deals By Year, 2014 to YTD 2020
Bio-Rad Laboratories Inc, Medical Equipment, Deals By Type, 2014 to YTD 2020
Bio-Rad Laboratories Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Mar 02, 2020: BIO-RAD LABORATORIES: Departure of directors or certain officers; election of directors; appointment of certain officers; compensatory arrangements of certain officers.
Feb 13, 2020: Bio-Rad reports fourth-quarter and full-year 2019 financial results
Feb 04, 2020: Bio-Rad brings FCS express flow cytometry analysis software to ZE5 cell analyzer users
Jan 06, 2020: Bio-Rad appoints Dara Grantham Wright Executive Vice President and Clinical Diagnostics Group President
Dec 23, 2019: The International Trade Commission issues final decision affirming 10X Genomics infringement of three of Bio-Rad’s Patents
Dec 23, 2019: The International Trade Commission issues final decision affirming 10X genomics infringement of three of Bio-Rad’s patents
Dec 13, 2019: Bio-Rad makes progress recovering from recent ransomware attack
Oct 31, 2019: Bio-Rad reports third-quarter 2019 financial results
Oct 31, 2019: Bio-Rad reports third-quarter 2019 financial results.
Sep 11, 2019: Bio-Rad files new lawsuit against 10X Genomics for Patent Infringement
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
List of Tables
Bio-Rad Laboratories Inc, Key Facts
Bio-Rad Laboratories Inc, Key Employees
Bio-Rad Laboratories Inc, Key Employee Biographies
Bio-Rad Laboratories Inc, Major Products and Services
Bio-Rad Laboratories Inc, History
Bio-Rad Laboratories Inc, Subsidiaries
Bio-Rad Laboratories Inc, Key Competitors
Bio-Rad Laboratories Inc, Ratios based on current share price
Bio-Rad Laboratories Inc, Annual Ratios
Bio-Rad Laboratories Inc, Annual Ratios (Cont...1)
Bio-Rad Laboratories Inc, Annual Ratios (Cont...2)
Bio-Rad Laboratories Inc, Interim Ratios
Bio-Rad Laboratories Inc, Medical Equipment, Deals By Year, 2014 to YTD 2020
Bio-Rad Laboratories Inc, Medical Equipment, Deals By Type, 2014 to YTD 2020
Bio-Rad Laboratories Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List of Figures
Bio-Rad Laboratories Inc, Performance Chart (2015 - 2019)
Bio-Rad Laboratories Inc, Ratio Charts
Bio-Rad Laboratories Inc, Medical Equipment, Deals By Year, 2014 to YTD 2020
Bio-Rad Laboratories Inc, Medical Equipment, Deals by Type, 2014 to YTD 2020